July 27, 2018 09:06 AM EDT
News Briefing

CHMP rec­om­mends OK for Al­ny­lam's patisir­an; Am­gen scraps a BC­MA ADC

John Carroll

Editor & Founder

→ Al­ny­lam $AL­NY took an­oth­er big step to­ward get­ting a Eu­ro­pean ap­proval for patisir­an. The biotech says that the CHMP rec­om­mend­ed an OK for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: White House threat­ens ‘most fa­vored na­tion’ plan to low­er US drug prices, but many ques­tions re­main

Trump says he'll sign or­der on 'most fa­vored na­tion' drug price plans Mon­day

Lil­ly says fur­ther head-to-head tri­al da­ta back Zep­bound over No­vo’s We­govy

Ex­clu­sive: Patrick Hsu start­up launch­es, looks be­yond CRISPR for gene in­ser­tion tech­nol­o­gy

Io­vance stock plum­mets af­ter low­ered full-year guid­ance, missed an­a­lyst ex­pec­ta­tions for Am­tagvi

Lil­ly shuf­fles key ex­ec­u­tive po­si­tions; Mikael Dol­sten takes an­oth­er post-Pfiz­er as­sign­ment

A service from the Financial Times